|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 30 April 2003
doi: 10.1242/jcs.00434
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Canadian Blood Services, R&D Department, 1800 Alta Vista Drive, Ottawa, ON
K1G 4J5, Canada
2 Department of Biochemistry, Microbiology, and Immunology, University of
Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada
3 Department of Biochemistry, Queens University, Room A212 Botterell Hall,
Kingston, ON K7L 3N6, Canada
4 Department of Pathology and Laboratory Medicine, University of British
Columbia, 2211 Wesbrook Mall, Room GF-114, Vancouver, BC V6T 2B5, Canada
* Author for correspondence (e-mail: ed.pryzdial{at}bloodservices.ca)
Accepted 20 February 2003
Cell-surface annexin 2 (A2) and its ligand p11 have been implicated in fibrinolysis because of their ability to accelerate tissue plasminogen activator (tPA)-mediated activation of plasminogen to plasmin. Because thrombin is a potent cell modulator obligately produced at the site of clot formation, we hypothesized that the amount of cell-surface A2 and p11 might be altered by thrombin with consequent effects on plasmin generation. In support of this hypothesis, immunofluorescence microscopy and hydrophilic biotinylation experiments showed that both A2 and p11 were significantly increased on the surface of human umbilical vein endothelial cells (HUVECs) treated with thrombin (0.8-8 nM) for 5 minutes followed by 1 hour at 37°C. Intracellular immunofluorescence microscopy and immunoblot analyses of whole cell extracts revealed increased p11 but unchanged A2 in response to thrombin, suggesting that transbilayer trafficking of A2 might be controlled by p11. The thrombin receptor-activating peptide (TRAP) similarly affected cells, demonstrating that cell signaling at least involved the type-1 protease activated receptor (PAR-1). An effect on the fibrinolysis pathway after treatment of HUVECs with thrombin was shown by increased fluorescein-labeled plasminogen binding to cells, which was inhibited by an antibody specific for p11. This was confirmed by observing that thrombin pretreatment of HUVECs increased biotin-modified plasminogen binding. Utilizing a chromogenic assay, pretreatment of HUVECs by thrombin further enhanced activation of the Glu and Lys forms of plasminogen by tPA. These data suggest a novel mechanism that links the coagulation and fibrinolysis pathways by thrombin-mediated feedback.
Key words: Annexin 2, Thrombin, Endothelial cell, Fibrinolysis, Coagulation
This article has been cited by other articles:
![]() |
K.-L. He, A. B. Deora, H. Xiong, Q. Ling, B. B. Weksler, R. Niesvizky, and K. A. Hajjar Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11 J. Biol. Chem., July 11, 2008; 283(28): 19192 - 19200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Patchell, K. R. Wojcik, T.-L. Yang, S. R. White, and D. R. Dorscheid Glycosylation and annexin II cell surface translocation mediate airway epithelial wound repair Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L354 - L363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Derry, M. R. Sutherland, C. M. Restall, D. M. Waisman, and E. L. G. Pryzdial Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5 J. Gen. Virol., January 1, 2007; 88(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Mambula and S. K. Calderwood Heat Shock Protein 70 Is Secreted from Tumor Cells by a Nonclassical Pathway Involving Lysosomal Endosomes J. Immunol., December 1, 2006; 177(11): 7849 - 7857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, S. Kondo, K. Mizuno, W. Yano, H. Nakao, Y. Hattori, K. Kimura, and T. Nishida Promotion of Corneal Epithelial Wound Healing In Vitro and In Vivo by Annexin A5 Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1862 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Laumonnier, T. Syrovets, L. Burysek, and T. Simmet Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes Blood, April 15, 2006; 107(8): 3342 - 3349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ganguly, M. S. Goel, T. Krasik, K. Bdeir, S. L. Diamond, D. B. Cines, V. R. Muzykantov, and J.-C. Murciano Fibrin Affinity of Erythrocyte-Coupled Tissue-Type Plasminogen Activators Endures Hemodynamic Forces and Enhances Fibrinolysis in Vivo J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Prudovsky, A. Mandinova, R. Soldi, C. Bagala, I. Graziani, M. Landriscina, F. Tarantini, M. Duarte, S. Bellum, H. Doherty, et al. The non-classical export routes: FGF1 and IL-1{alpha} point the way J. Cell Sci., December 15, 2003; 116(24): 4871 - 4881. [Abstract] [Full Text] [PDF] |
||||